12:00 AM
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Thyrogen thyrotropin alpha regulatory update

EMA's CHMP recommended changing the label of thyroid cancer treatment Thyrogen thyrotropin alpha from Sanofi's Genzyme Corp. subsidiary to include a radioiodine dose range. Specifically, Thyrogen would...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >